A Study of SGN-CD228A in Advanced Solid Tumors

Conditions:   Cutaneous Melanoma;   Pleural Mesothelioma;   Breast Cancer;   Non-small Cell Lung Cancer;   Colorectal Cancer;   Pancreatic Ductal Adenocarcinoma Intervention:   Drug: SGN-CD228A Sponsor:   Seattle Genetics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials